Encompass Health <EHC.N>: Barclays raises target price to $144 from $140
EHC•Related News
Immunocore Q2 FY26 net loss narrows to $0.8 million; revenue rises 18% to $115.9 million
IMCR•
Tarsus to buy Alkeus in deal worth about $450 million upfront
TARS•
Encore Capital Group, Inc. <ECPG.O>: Truist Securities raises target price to $112 from $105
ECPG•
Dianthus Therapeutics Inc <DNTH.O>: Truist Securities Raises Target Price to $128 From $110
DNTH•
Harrow to buy dry eye nasal spray Tyrvaya from Viatris for up to $100 million
HROW•